Akoustis Announces Two Lecture Presentations at the 2020 IEEE International Ultrasonics Symposium
– IEEE IUS is One of the World’s Pre-eminent Forums for Technical Breakthroughs –– First Lecture Details Company’s 40-Watt Power-Handling, […]
Kymera Therapeutics Appoints Biopharma Veterans Pamela Esposito and Jeff Albers to its Board of Directors
WATERTOWN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and […]
BioXcel Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
NEW HAVEN, Conn., Sept. 09, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical […]
Kaleido Biosciences to Present at Upcoming September Investor Conferences
LEXINGTON, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced that Michael Bonney, Executive Chair, […]
Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A, an Investigational Allogeneic CAR T Therapy for Relapsed/Refractory Multiple Myeloma
DURHAM, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to […]
aTyr Pharma to Present at September Investor Conferences
SAN DIEGO, Sept. 09, 2020 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery […]
ADMA Biologics to Participate in Morgan Stanley Virtual Healthcare Conference
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 09, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the […]
Orchard Therapeutics to Present at Upcoming Virtual Investor Conferences
BOSTON and LONDON, Sept. 09, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced […]
TSX News -
Live Webinar and Q&A today, Marimaca Project PEA Results: US$524 million post-tax real NPV8 and 33.5% IRR
The Preliminary Economic Assessment (“PEA”) was prepared in accordance with the requirements of the National Instrument 43-101,Standards of Disclosure for […]
Arco Platform Limited Announces Pricing of Public Primary Offering of Class A Common Shares
SÃO PAULO, Brazil, Sept. 09, 2020 (GLOBE NEWSWIRE) — Arco Platform Limited, or Arco (Nasdaq: ARCE), announced today that it […]
